Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a severe autoimmune disease that displays considerable heterogeneity not only in its symptoms, but also in its environmental and genetic causes. Studies in SLE patients have revealed that many genetic variants contribute to disease development. However, often it...

Full description

Bibliographic Details
Main Authors: Marina A. Korn, Marie Steffensen, Carolin Brandl, Dmytro Royzman, Christoph Daniel, Thomas H. Winkler, Lars Nitschke
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1095830/full
_version_ 1827997125398495232
author Marina A. Korn
Marie Steffensen
Carolin Brandl
Dmytro Royzman
Dmytro Royzman
Christoph Daniel
Thomas H. Winkler
Lars Nitschke
author_facet Marina A. Korn
Marie Steffensen
Carolin Brandl
Dmytro Royzman
Dmytro Royzman
Christoph Daniel
Thomas H. Winkler
Lars Nitschke
author_sort Marina A. Korn
collection DOAJ
description Systemic lupus erythematosus (SLE) is a severe autoimmune disease that displays considerable heterogeneity not only in its symptoms, but also in its environmental and genetic causes. Studies in SLE patients have revealed that many genetic variants contribute to disease development. However, often its etiology remains unknown. Existing efforts to determine this etiology have focused on SLE in mouse models revealing not only that mutations in specific genes lead to SLE development, but also that epistatic effects of several gene mutations significantly amplify disease manifestation. Genome-wide association studies for SLE have identified loci involved in the two biological processes of immune complex clearance and lymphocyte signaling. Deficiency in an inhibitory receptor expressed on B lymphocytes, Siglec-G, has been shown to trigger SLE development in aging mice, as have mutations in DNA degrading DNase1 and DNase1l3, that are involved in clearance of DNA-containing immune complexes. Here, we analyze the development of SLE-like symptoms in mice deficient in either Siglecg and DNase1 or Siglecg and DNase1l3 to evaluate potential epistatic effects of these genes. We found that germinal center B cells and follicular helper T cells were increased in aging Siglecg-/- x Dnase1-/- mice. In contrast, anti-dsDNA antibodies and anti-nuclear antibodies were strongly increased in aging Siglecg-/- x Dnase1l3-/- mice, when compared to single-deficient mice. Histological analysis of the kidneys revealed glomerulonephritis in both Siglecg-/- x Dnase1-/- and Siglecg-/- x Dnase1l3-/- mice, but with a stronger glomerular damage in the latter. Collectively, these findings underscore the impact of the epistatic effects of Siglecg with DNase1 and Dnase1l3 on disease manifestation and highlight the potential combinatory effects of other gene mutations in SLE.
first_indexed 2024-04-10T05:23:36Z
format Article
id doaj.art-64c20df68051432f9f311146a4f6e232
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T05:23:36Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-64c20df68051432f9f311146a4f6e2322023-03-08T05:02:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-03-011410.3389/fimmu.2023.10958301095830Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosusMarina A. Korn0Marie Steffensen1Carolin Brandl2Dmytro Royzman3Dmytro Royzman4Christoph Daniel5Thomas H. Winkler6Lars Nitschke7Division of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanyDivision of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanyDivision of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanyDivision of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanyDepartment of Immune Modulation, University Hospital of Erlangen, Erlangen, GermanyDepartment of Nephropathology, University Hospital of Erlangen, Erlangen, GermanyDivision of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanyDivision of Genetics, Department of Biology, University of Erlangen, Erlangen, GermanySystemic lupus erythematosus (SLE) is a severe autoimmune disease that displays considerable heterogeneity not only in its symptoms, but also in its environmental and genetic causes. Studies in SLE patients have revealed that many genetic variants contribute to disease development. However, often its etiology remains unknown. Existing efforts to determine this etiology have focused on SLE in mouse models revealing not only that mutations in specific genes lead to SLE development, but also that epistatic effects of several gene mutations significantly amplify disease manifestation. Genome-wide association studies for SLE have identified loci involved in the two biological processes of immune complex clearance and lymphocyte signaling. Deficiency in an inhibitory receptor expressed on B lymphocytes, Siglec-G, has been shown to trigger SLE development in aging mice, as have mutations in DNA degrading DNase1 and DNase1l3, that are involved in clearance of DNA-containing immune complexes. Here, we analyze the development of SLE-like symptoms in mice deficient in either Siglecg and DNase1 or Siglecg and DNase1l3 to evaluate potential epistatic effects of these genes. We found that germinal center B cells and follicular helper T cells were increased in aging Siglecg-/- x Dnase1-/- mice. In contrast, anti-dsDNA antibodies and anti-nuclear antibodies were strongly increased in aging Siglecg-/- x Dnase1l3-/- mice, when compared to single-deficient mice. Histological analysis of the kidneys revealed glomerulonephritis in both Siglecg-/- x Dnase1-/- and Siglecg-/- x Dnase1l3-/- mice, but with a stronger glomerular damage in the latter. Collectively, these findings underscore the impact of the epistatic effects of Siglecg with DNase1 and Dnase1l3 on disease manifestation and highlight the potential combinatory effects of other gene mutations in SLE.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1095830/fullB cell signalingmouse modelsinhibitory receptorslymphocytesautoimmunity
spellingShingle Marina A. Korn
Marie Steffensen
Carolin Brandl
Dmytro Royzman
Dmytro Royzman
Christoph Daniel
Thomas H. Winkler
Lars Nitschke
Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
Frontiers in Immunology
B cell signaling
mouse models
inhibitory receptors
lymphocytes
autoimmunity
title Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
title_full Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
title_fullStr Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
title_full_unstemmed Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
title_short Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
title_sort epistatic effects of siglec g and dnase1 or dnase1l3 deficiencies in the development of systemic lupus erythematosus
topic B cell signaling
mouse models
inhibitory receptors
lymphocytes
autoimmunity
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1095830/full
work_keys_str_mv AT marinaakorn epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT mariesteffensen epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT carolinbrandl epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT dmytroroyzman epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT dmytroroyzman epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT christophdaniel epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT thomashwinkler epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus
AT larsnitschke epistaticeffectsofsiglecganddnase1ordnase1l3deficienciesinthedevelopmentofsystemiclupuserythematosus